# Dexlansoprazole MR-Based Concomitant Quadruple Therapy

> **NCT03829150** · NA · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 202 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Dexlan
- **DRUG:** Amoxicillin
- **DRUG:** Clarithromycin 500mg
- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT03829150
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-01
- **Primary completion:** 2019-04-20
- **Final completion:** 2019-04-20
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2019-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03829150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03829150, "Dexlansoprazole MR-Based Concomitant Quadruple Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03829150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*